Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2

Millions of people are affected by COVID-19 since the last quarter of 2019. Treatment using hydroxychloroquine (HCQ) as monotherapy in combination with azithromycin (HCQ-AZ) were administered at several clinical centres to patients tested positive to the virus across continents. Therefore, it is of...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Jitender, Malik, Deepti, Raina, Ashvinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340690/
https://www.ncbi.nlm.nih.gov/pubmed/34393413
http://dx.doi.org/10.6026/97320630017011
_version_ 1783733818757218304
author Singh, Jitender
Malik, Deepti
Raina, Ashvinder
author_facet Singh, Jitender
Malik, Deepti
Raina, Ashvinder
author_sort Singh, Jitender
collection PubMed
description Millions of people are affected by COVID-19 since the last quarter of 2019. Treatment using hydroxychloroquine (HCQ) as monotherapy in combination with azithromycin (HCQ-AZ) were administered at several clinical centres to patients tested positive to the virus across continents. Therefore, it is of interest to document the molecular docking analysis data of azithromycin and hydroxychloroquine drug with the spike surface glycoprotein of novel COVID-19. Thus, we report the molecular modelling docking based structural binding features of HCQ-AZ with the spike surface glycoprotein of COVID-19 for further evaluation in this regard.
format Online
Article
Text
id pubmed-8340690
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Biomedical Informatics
record_format MEDLINE/PubMed
spelling pubmed-83406902021-08-12 Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2 Singh, Jitender Malik, Deepti Raina, Ashvinder Bioinformation Research Article Millions of people are affected by COVID-19 since the last quarter of 2019. Treatment using hydroxychloroquine (HCQ) as monotherapy in combination with azithromycin (HCQ-AZ) were administered at several clinical centres to patients tested positive to the virus across continents. Therefore, it is of interest to document the molecular docking analysis data of azithromycin and hydroxychloroquine drug with the spike surface glycoprotein of novel COVID-19. Thus, we report the molecular modelling docking based structural binding features of HCQ-AZ with the spike surface glycoprotein of COVID-19 for further evaluation in this regard. Biomedical Informatics 2021-01-31 /pmc/articles/PMC8340690/ /pubmed/34393413 http://dx.doi.org/10.6026/97320630017011 Text en © 2021 Biomedical Informatics https://creativecommons.org/licenses/by/3.0/This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
spellingShingle Research Article
Singh, Jitender
Malik, Deepti
Raina, Ashvinder
Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
title Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
title_full Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
title_fullStr Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
title_full_unstemmed Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
title_short Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
title_sort molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of sars-cov-2
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340690/
https://www.ncbi.nlm.nih.gov/pubmed/34393413
http://dx.doi.org/10.6026/97320630017011
work_keys_str_mv AT singhjitender moleculardockinganalysisofazithromycinandhydroxychloroquinewithspikesurfaceglycoproteinofsarscov2
AT malikdeepti moleculardockinganalysisofazithromycinandhydroxychloroquinewithspikesurfaceglycoproteinofsarscov2
AT rainaashvinder moleculardockinganalysisofazithromycinandhydroxychloroquinewithspikesurfaceglycoproteinofsarscov2

Ejemplares similares